← Back to Clinical Trials
Recruiting NCT06056037

NCT06056037 Making ART Work Among Brazilian Youth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06056037
Status Recruiting
Phase
Sponsor Brown University
Condition Hiv
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2023-10-01
Primary Completion 2026-04-30

Trial Parameters

Condition Hiv
Sponsor Brown University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 72
Sex MALE
Min Age 18 Years
Max Age 24 Years
Start Date 2023-10-01
Completion 2026-04-30
Interventions
Experimental: Making ART WorkStandard of Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.

Eligibility Criteria

Inclusion Criteria: * between 18 and 24 years of age * assigned male sex at birth * identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum * self-report living with HIV, and verified by medical chart review, * self-report currently taking or prescribed ART for \> 3 months * self-report missing 2 or more doses of ART medications in any given week in the past month OR not virally suppressed (i.e., \>40 copies/mL in past 3 months; via national outpatient data \[SISCEL\] or plasma viral load testing) * owns a cell phone or willing to use one as part of the study Exclusion Criteria: * unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication * unable to read and/or write to an extent that would limit their ability to comprehend the informed consent * lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology